- TWD3.94bn
- TWD3.06bn
- TWD162.49m
- 33
- 10
- 52
- 18
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 95.5 | 91.8 | 169 | 135 | 162 |
Cost of Revenue | |||||
Gross Profit | 63.6 | 45.5 | 78.3 | 57 | 67.6 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 331 | 266 | 301 | 292 | 284 |
Operating Profit | -236 | -174 | -132 | -157 | -122 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -205 | -116 | -95.5 | -115 | -74.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -205 | -119 | -95.5 | -115 | -74.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -171 | -88.2 | -77.7 | -79.4 | -47.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -171 | -88.2 | -77.7 | -79.4 | -47.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.826 | -0.6 | -0.397 | -0.4 | -0.236 |
Dividends per Share |